Barkby Group Plc. has completed a successful reverse takeover, placing and subscription
The management team of Barkby Group Plc. has completed a reverse takeover of Tarncourt Ambit Properties Limited, Tarncourt Ambit Limited and Workshop Trading Holdings Limited.
Barkby Group is built on a diverse portfolio of businesses within evolving markets. It comprises three separate divisions: life sciences, real estate and consumer and hospitality. Life sciences includes Cambridge Sleep Sciences, which has rights to the exclusive design and production of the SleepHub™ device to improve and facilitate natural sleep, and Vivoplex, a digital health company aiming to transform fertility treatments with precision medicine. The group’s commercial property development specializes in developing contract-backed sites in the southeast of England. The company has a proven profitable track record of sourcing and developing commercial property projects. The consumer and hospitality portfolio is comprised of three separate growth businesses: Workshop Coffee, Barkby Pubs and Centurian Automotive.
During this process, Oaklins Cavendish’s sister firm finnCap, based in the UK, initiated and advised on many aspects, including, among others, securing pre-commitments from cornerstone investors, deal structuring, and the reverse pricing and sizing.
Talk to the deal team
Related deals
Kaviari has received a minority investment from idiCo
Kaviari has received a minority investment from a pool of investors led by idiCo, alongside Bpifrance, IRD Invest and UI Investissement.
Learn moreAWC has acquired a significant minority stake in MyFitness
AWC AS, the investment company of the Norwegian family office Awilhelmsen, has acquired a 22.2% stake in MyFitness AS, the largest fitness club operator in the Baltics, becoming the MyFitness’ largest single shareholder.
Learn moreInstituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn more